PANACUR (fenbendazole) Paste 10% (100 mg/g) Equine Dewormer – FDA-approved label (SPL) (2026)

Government Record · Merck Sharp & Dohme Corp. (labeler) · November 5, 2026

Merck Sharp & Dohme Corp. (labeler), 2026-11-05: The current FDA-approved label for Panacur Paste 10%, an equine dewormer labelled by Merck Sharp & Dohme Corp. and distributed by Intervet Inc. d/b/a Merck Animal Health. It gives the horse indications, the 5 mg/kg and 10 mg/kg dose schedules and the warning 'NOT FOR USE IN HUMANS'.

Panacur ® Paste 10% is indicated for the treatment and control of large strongyles (Strongylus edentatus, S. equinus, S. vulgaris), encysted early 3rd stage (hypobiotic), late 3rd stage and 4th stage cyathostome larvae, small strongyles, pinworms (Oxyuris equi), ascarids (Parascaris equorum)

Merck Sharp & Dohme Corp. (labeler), 2026-11-05: The current FDA-approved label for Panacur Paste 10%, an equine dewormer labelled by Merck Sharp & Dohme Corp. and distributed by Intervet Inc. d/b/a Merck Animal Health. It gives the horse indications, the 5 mg/kg and 10 mg/kg dose schedules and the warning 'NOT FOR USE IN HUMANS'. Label version 16, published 13 November 2026 (access date 2026-11-19). Label states 'Distributed by: Intervet Inc. (d/b/a Merck Animal Health) Rahway, NJ 07065' and 'Approved by FDA under NADA # 120-648'. Contains the boxed-style warning 'NOT FOR USE IN HUMANS. KEEP OUT OF REACH OF CHILDREN.' and 'Do not use in horses intended for human consumption.' Copyright: SPL label text carries a Merck copyright notice (2026 Merck & Co., Inc.) while being an FDA-approved label – classed Copyrighted conservatively. Study type: regulatory record.